East Weymouth, MANCT07230834Now EnrollingIRB Ready

Geographic Atrophy (GA) Clinical Trial in East Weymouth, MA

Access cutting-edge geographic atrophy (ga) treatment through this clinical trial at a research site in East Weymouth. Study-provided care at no cost to qualified participants.

Sponsored by Regeneron Pharmaceuticals

Quick Self-Assessment

See if you qualify for this East Weymouth location

Preparing your pre-screening questions…

Expert Care in East Weymouth

Access geographic atrophy (ga) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related geographic atrophy (ga) treatment provided free

Apply for This East Weymouth Location

Check if you qualify for this geographic atrophy (ga) clinical trial in East Weymouth, MA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to East Weymouth

    Convenient for MA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit East Weymouth site if eligible
  4. 4Begin participation

About This Geographic Atrophy (GA) Study in East Weymouth

This study is researching an experimental drug called pozelimab (called "study drug"). The study is focused on people with a condition where certain parts of the eye's retina stop working over time, which can make it harder to see. This is called geographic atrophy (GA). The aim of the study is to see how safe and tolerable the study drug is when used as an injection in the eye. The study is looking at several other research questions, including: * What side effects may happen from taking the study drug * How much study drug is in the blood and the fluid in the eye at different times * Whether the body makes antibodies against the study drug (which could make the drug less effective or could lead to side effects)

Sponsor: Regeneron Pharmaceuticals

Who Can Participate

Inclusion Criteria

Study eye with diagnosis of GA of the macula secondary to AMD, as determined by the investigator
Study eye with total GA area measuring approximately one disc area or greater in size (2.5 mm\^2 or larger) at screening, as determined by the Central Reading Center (CRC), as described in the protocol
Best-Corrected Visual Acuity (BCVA) of 60 letters or worse using the Early Treatment Diabetic Retinopathy Score (ETDRS) charts (Snellen equivalent of \~ ≤20/63) in the study eye at screening and baseline visit Key

Exclusion Criteria

GA (macular atrophy) in either eye due to causes other than dry AMD
History or current evidence of macular neovascularization and/or retinal exudation in either eye
Concurrent eye disease (elevated Intraocular Pressure (IOP) \>25mm Hg, diabetic retinopathy, ocular infections/inflammation)
Prior or current intravitreal (IVT) treatment of any kind for any indication in either the study or fellow eye, except complement inhibitor therapy for GA, as long as last dose was ≥3 months prior to screening
Any prior systemic treatment for dry AMD, except oral supplements or vitamins
History or current use of systemic complement inhibitor therapy Note: Other protocol-defined Inclusion/ Exclusion criteria apply

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in East Weymouth?

Yes, this clinical trial (NCT07230834) has an active research site in East Weymouth, MA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Geographic Atrophy (GA) Treatment Options in East Weymouth, MA

If you're searching for geographic atrophy (ga) treatment options in East Weymouth, MA, this clinical trial (NCT07230834) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our East Weymouth research site is actively enrolling participants for this clinical trial. You'll receive care from experienced geographic atrophy (ga) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all geographic atrophy (ga) clinical trials near you to find additional studies recruiting in your area.

More Rheumatoid Arthritis Trials in East Weymouth, MA

See all rheumatoid arthritis clinical trials recruiting in East Weymouth — not just this study.

Browse Rheumatoid Arthritis Trials in East Weymouth

Ready to Join in East Weymouth?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · East Weymouth, MA